Settings
ILMN [NASD]
Illumina Inc.
Index- P/E105.59 EPS (ttm)1.91 Insider Own1.20% Shs Outstand142.00M Perf Week9.72%
Market Cap28.64B Forward P/E63.58 EPS next Y3.17 Insider Trans-24.03% Shs Float140.32M Perf Month9.91%
Income280.70M PEG4.22 EPS next Q0.78 Inst Own95.70% Short Float1.67% Perf Quarter8.52%
Sales1.74B P/S16.49 EPS this Y-20.40% Inst Trans0.29% Short Ratio1.97 Perf Half Y17.92%
Book/sh9.03 P/B22.33 EPS next Y19.74% ROA9.10% Target Price211.50 Perf Year45.49%
Cash/sh8.95 P/C22.53 EPS next 5Y25.03% ROE20.60% 52W Range127.69 - 199.48 Perf YTD9.26%
Dividend- P/FCF76.59 EPS past 5Y24.60% ROI3.90% 52W High1.10% Beta0.85
Dividend %- Quick Ratio2.00 Sales past 5Y19.90% Gross Margin67.50% 52W Low57.95% ATR7.38
Employees3000 Current Ratio2.20 Sales Q/Q34.70% Oper. Margin23.30% RSI (14)61.67 Volatility4.06% 3.87%
OptionableYes Debt/Eq1.01 EPS Q/Q186.40% Profit Margin16.20% Rel Volume1.11 Prev Close197.16
ShortableYes LT Debt/Eq0.77 EarningsJan 27 AMC Payout0.00% Avg Volume1.18M Price201.68
Recom2.00 SMA206.49% SMA507.36% SMA20017.85% Volume1,314,600 Change2.29%
Jan-07-15Initiated Barclays Equal Weight $210
Oct-27-14Reiterated Stifel Buy $200 → $215
Oct-21-14Reiterated ISI Group Neutral $175 → $180.50
Aug-12-14Initiated Stifel Buy $200
Aug-01-14Initiated Tigress Financial Buy
Jul-24-14Reiterated Mizuho Buy $200 → $220
Jul-17-14Reiterated Maxim Group Buy $205 → $220
Apr-23-14Upgrade Maxim Group Hold → Buy $205
Apr-23-14Reiterated Mizuho Buy $175 → $200
Apr-23-14Reiterated ISI Group Neutral $152.50 → $162.50
Feb-19-14Reiterated UBS Buy $152 → $202
Jan-29-14Reiterated Mizuho Buy $150 → $175
Jan-29-14Reiterated ISI Group Neutral $134.50 → $147
Jan-17-14Reiterated Mizuho Buy $135 → $150
Jan-14-14Reiterated Mizuho Buy $125 → $135
Dec-19-13Reiterated Mizuho Buy $100 → $125
Oct-22-13Reiterated Mizuho Buy $86 → $100
Oct-22-13Reiterated Barclays Overweight $85 → $90
Jul-24-13Reiterated Mizuho Buy $83 → $86
Jul-24-13Reiterated ISI Group Neutral $75 → $78.50
Jan-27-15 07:07AM  Q4 2014 Illumina Inc Earnings Release - After Market Close CCBN
Jan-26-15 06:42PM  Big Cap Stocks Mylan, American Tower Near Buy Points at Investor's Business Daily
Jan-23-15 06:34PM  IBD 50 Turns In Solid Week As Market Uptrend Resumes at Investor's Business Daily
02:00PM  Can Illumina (ILMN) Keep the Earnings Streak Alive in Q4? - Analyst Blog Zacks
01:44PM  Putting the spotlight on Illumina at MarketWatch
09:30AM  Sequential Brands Group, Westlake Chemical, Hologic, McKesson and Illumina highlighted as Zacks Bull and Bear of the Day - Press Releases Zacks
08:46AM  Should You Buy Illumina (ILMN) Ahead of Earnings? - Tale of the Tape Zacks
Jan-22-15 05:50PM  Illumina Launches MiSeq FGx for Forensic DNA Analysis - Analyst Blog Zacks
12:45PM  Top 3 MedTech Stocks Poised to Gain this Earnings Season - Earnings ESP Zacks
Jan-21-15 05:09PM  3 High-Flying Health Care Stock IPOs To Watch In 2015 at Investor's Business Daily
02:49PM  Stocks Fade In Late Trade; Netflix Stays Strong at Investor's Business Daily
01:07PM  Midday movers: Exxon Mobil, Amazon, Boeing & more at CNBC
10:32AM  Stocks Narrowly Mixed, Dow Lags As IBM Revenue, Outlook Miss at Investor's Business Daily
06:30AM  Illumina Announces First Targeted Next-Generation Sequencing Solution for Forensic Genomics Business Wire
Jan-20-15 06:45PM  Illumina rose 7% Investor's Business Daily +7.02%
05:55PM  Illumina Makes Big Move Ahead Of Obama's Address at Investor's Business Daily
04:19PM  Taking Stock: Winners and Losers, Stock of the Day at Bloomberg
12:20PM  Will ResMed (RMD) Surprise Earnings Estimates in Q2? - Analyst Blog Zacks
Jan-16-15 02:30PM  Illumina Unveils 3 NGS Systems, Modifies Business Strategy - Analyst Blog Zacks
Jan-15-15 02:40PM  Illumina Declares Impressive Q4, 2014 Preliminary Results - Analyst Blog Zacks
Jan-14-15 05:30PM  Fluidigm's Preliminary Q4 Revenues Up Y/Y, Outlook Positive - Analyst Blog Zacks
07:00AM  Leader in Genomic Sequencing Illuminates the Way Morningstar
Jan-13-15 06:30AM  Illumina to Announce Fourth Quarter and Fiscal Year 2014 Financial Results on Tuesday, January 27, 2015 Business Wire
Jan-12-15 06:30PM  Hot Big Caps: Valeant, Illumina, Chipotle Break Out at Investor's Business Daily
04:23PM  Stocks Close Sharply Lower; Medicals Move On Announcements at Investor's Business Daily
03:04PM  Stocks Trade Near Session Lows; Illumina Tumbles at Investor's Business Daily
02:40PM  Lockheed Martin and Illumina to Collaborate on Developing Genomics Solutions to Improve Public Health and Wellness Business Wire
02:32PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
02:30PM  Illumina Expands Worlds Most Comprehensive Next-Generation Sequencing Portfolio Business Wire
08:00AM  Stealthy 10X Genomics Raises $55.5M To Beef Up DNA Sequencing at Forbes
01:05AM  Roche Spends $1.03 Billion For Majority Stake In Foundation Medicine at Forbes
Jan-11-15 07:00PM  ¬£15m Initiative Puts Scotland at Forefront of Gene-Led Healthcare Business Wire
Jan-08-15 06:06PM  BioMed Realty Signs Deal To Build Campus For Illumina at Investor's Business Daily
10:40AM  Facebook, Chip Stocks Shine In Q4 Earnings Revisions at Investor's Business Daily
06:30AM  Illumina Announces African Orphan Crops Consortium to Receive Agricultural Greater Good Initiative Grant Business Wire
Jan-07-15 01:34PM  Stocks Stay Near Day's Highs, But Volume Eases Some at Investor's Business Daily
01:00PM  Coverage initiated on Illumina by Barclays Briefing.com
11:44AM  Adaptive Buys Sequenta to Disrupt Cancer Diagnosis, Drug Discovery at Forbes
Jan-06-15 07:51PM  Top Stock Buys And Sells: Illumina Favored at Investor's Business Daily
Jan-05-15 04:40PM  Illumina inks 15-year lease for massive BioMed project in Foster City at bizjournals.com
04:11PM  ILLUMINA INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
04:01PM  BioMed Realty And Illumina To Create New 360,000 Square Foot World-Class Life Science Campus In Foster City, CA PR Newswire
11:48AM  Stocks Extend Morning Losses; Crude Oil Falls To New Low at Investor's Business Daily
10:33AM  Stocks Drop 1% In Rising Volume; Visa Falls 1% at Investor's Business Daily
Jan-02-15 10:31AM  Stocks Start New Year With Gains; Intel Jumps at Investor's Business Daily
Dec-31-14 04:53PM  Will Health Yield Wealth For Recent IPO INC Research? at Investor's Business Daily
Dec-30-14 05:16PM  Recent IPO PRA Health Sciences Finds Growth In Buyout at Investor's Business Daily
Dec-22-14 06:30AM  Illumina to Webcast Live Presentation at the J.P. Morgan Annual Healthcare Conference Business Wire
Dec-18-14 11:51AM  Stocks Up Big; Restoration, Accenture Hit New Highs at Investor's Business Daily
Dec-17-14 01:24PM  Stocks Hold Near Highs Ahead of Fed Announcement at Investor's Business Daily
Dec-15-14 01:29PM  Stocks Stage Comeback; Leaders Still Under Pressure at Investor's Business Daily
Dec-10-14 05:57AM  Kite Pharma (KITE) Shows Strength: Stock Moves Up 16.4% Zacks
05:53AM  Celladon Corp. (CLDN) Jumps: Stock Adds 14.7% in Session Zacks
Dec-09-14 05:50AM  bluebird bio (BLUE) in Focus: Stock Surges 9.4% Zacks
Dec-08-14 06:30AM  uniQure N.V. (QURE) Jumps: Stock Adds 6.3% in Session Zacks
Dec-06-14 04:06AM  My 2014 Healthcare Top 10 List at Forbes
Dec-05-14 04:16PM  ILLUMINA INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Dec-04-14 05:45PM  Amgen's Blincyto Gets FDA Nod, Carries Boxed Warning Zacks
Dec-03-14 05:00PM  Tesla hits oil slick CNBC
12:14PM  Sequenom (SQNM) Stock Spikes Following NIPT Patent Settlement With Illumina at TheStreet
10:58AM  Sequenom climbs as Illumina patent dispute ends AP
10:42AM  Mid-Morning Market Update: Markets Mixed; Abercrombie & Fitch Lowers Earnings Guidance Benzinga
06:28AM  ImmunoCellular Therapeutics (IMUC) Soars: Stock Rises 40.9% Zacks
06:00AM  Illumina and Sequenom Pool Noninvasive Prenatal Testing Intellectual Property and End Outstanding Patent Disputes Business Wire
02:50AM  UK wage conundrum in spotlight ahead of Autumn Statement CNBC
Dec-02-14 05:14PM  Alexandria Real Estate REIT Inks Rx For Pharma Boom at Investor's Business Daily
07:48AM  Intra-Cellular Therapies (ITCI) Jumps: Stock Rises 6.8% Zacks
Nov-28-14 05:35AM  Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% Zacks
Nov-21-14 04:20PM  Is Illumina (ILMN) Worth Adding to Your Portfolio? Zacks
10:24AM  Covenant Transport (CVTI) & Inteliquent (IQNT): Top Stocks to Add to Your Momentum Portfolio Zacks
08:02AM  Meet 5 Top Stocks With Rising Earnings Estimates at Investor's Business Daily
Nov-19-14 05:01PM  The Forbes Healthcare Summit 2014: The Agenda at Forbes
04:15PM  Fluidigm's (FLDM) New Workflow to Allow High Throughput Zacks
02:20PM  Illumina, bioMerieux to Co-develop NGS Epidemiology Solution Zacks
11:21AM  Illumina teams with U.S. government, researchers to sequence Ebola Reuters
06:00AM  USAID, Broad Institute and Illumina Form a Public-Private Partnership Combating the Ebola Epidemic in West Africa Business Wire
Nov-18-14 01:00AM  bioM√©rieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections Business Wire
Nov-14-14 09:35PM  Big Ideas, Big Picture at Barrons.com
06:47PM  Medical Stocks Tumble But Most Of IBD 50 Trading Well at Investor's Business Daily
04:27PM  ILLUMINA INC Files SEC form 8-K, Other Events EDGAR Online
04:21PM  Stock Market Treads Water; Earnings Drive BitAuto at Investor's Business Daily
01:32PM  Stocks Mixed; Amazon Jumps On Book Deal at Investor's Business Daily
Nov-13-14 01:20PM  Qiagen Partners with Novartis for Companion Diagnostics Zacks
Nov-11-14 09:10AM  New Cancer Detection Technique Has Enormous Potential for Life Science Stocks at 24/7 Wall St.
05:37AM  Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% Zacks
Nov-10-14 09:37PM  Why this expert is buying into gold CNBC
07:34PM  Big Cap 20 Stuffed With Medical Names at Investor's Business Daily
Nov-06-14 06:41PM  Top Large-Cap Growth Mutual Funds Defy Gravity at Investor's Business Daily
06:41PM  Accumulation/Distribution Rating Tells You What Pros Are Doing Investor's Business Daily
06:00AM  'Mad Money' Lightning Round: Pull the Trigger on Baxter at TheStreet
Nov-05-14 04:08PM  ILLUMINA INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year EDGAR Online
01:04PM  ILLUMINA INC Financials EDGAR Online Financials
Nov-04-14 03:35PM  Taking Stock: Wood on Investing in Illumina, Tesla, Twitter at Bloomberg
05:32AM  Geron Corporation (GERN) Looks Strong: Stock Up 25.6% Zacks
Nov-03-14 10:42AM  Rothberg Returns With Star Trek-Like Medical Device To Create Images And Cut With Sound Waves at Forbes
02:23AM  Prosensa Holding N.V. (RNA) Jumps: Stock Moves Up 9.9% Zacks
Oct-31-14 08:08PM  10-Q for Illumina, Inc. Company Spotlight
06:47PM  IBD 50 Caps Impressive 2-Week Rally at Investor's Business Daily
08:13AM  Incyte (INCY) Looks Good: Stock Moves 10.9% Higher Zacks
03:11AM  Bristol-Myers Squibb (BMY) Jumps: Stock Moves Up 8.9% Zacks
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has strategic partnerships with AstraZeneca PLC; Janssen Biotech, Inc.; and Sanofi to focus on the transition from single-analyte companion diagnostics to panel-based assays that select for companion therapeutics. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FLATLEY JAY TChief Executive OfficerJan 22Option Exercise20.0425,000501,000390,478Jan 23 08:06 PM
FLATLEY JAY TChief Executive OfficerJan 22Sale188.4825,0004,712,079365,478Jan 23 08:06 PM
RASTETTER WILLIAM HDirectorJan 20Option Exercise6.2316,00099,60021,953Jan 22 03:19 PM
WALT DAVID RDirectorJan 20Option Exercise6.234,00024,900860,930Jan 22 05:54 PM
RASTETTER WILLIAM HDirectorJan 20Sale188.9916,0003,023,8945,953Jan 22 03:19 PM
WALT DAVID RDirectorJan 20Sale194.364,000777,420856,930Jan 22 05:54 PM
WALT DAVID RDirectorJan 20Sale194.432,000388,85474,960Jan 22 05:54 PM
WALT DAVID RDirectorJan 13Option Exercise6.234,00024,900860,930Jan 15 07:42 PM
WALT DAVID RDirectorJan 13Sale187.064,000748,250856,930Jan 15 07:42 PM
FLATLEY JAY TChief Executive OfficerJan 08Option Exercise20.0425,000501,000390,478Jan 09 07:30 PM
FLATLEY JAY TChief Executive OfficerJan 08Sale197.6225,0004,940,542365,478Jan 09 07:30 PM
WALT DAVID RDirectorJan 06Option Exercise6.234,00024,900860,930Jan 08 06:28 PM
WALT DAVID RDirectorJan 06Sale188.564,000754,240856,930Jan 08 06:28 PM
WALT DAVID RDirectorJan 06Sale188.522,000377,03176,960Jan 08 06:28 PM
Bouchard MichelVP, Finance & Chief AccountingJan 02Option Exercise69.3463143,75426,665Jan 05 07:35 PM
EASTHAM KARINDirectorJan 02Option Exercise36.2910,000362,90019,726Jan 05 07:35 PM
Bouchard MichelVP, Finance & Chief AccountingJan 02Sale186.17631117,47326,034Jan 05 07:35 PM
EASTHAM KARINDirectorJan 02Sale185.6310,0001,856,2519,726Jan 05 07:35 PM
WALT DAVID RDirectorDec 30Sale186.955,000934,741859,630Dec 30 06:28 PM
MOELLER GERALDDirectorDec 29Option Exercise42.818,000342,48025,457Dec 29 07:39 PM
MOELLER GERALDDirectorDec 29Sale187.058,0001,496,43917,457Dec 29 07:39 PM
Dadswell CharlesSr VP & General CounselDec 29Sale188.2014627,47743,260Dec 29 07:39 PM
FLATLEY JAY TChief Executive OfficerDec 26Option Exercise20.0425,000501,000390,478Dec 29 07:39 PM
FLATLEY JAY TChief Executive OfficerDec 26Sale186.7125,0004,667,817365,478Dec 29 07:39 PM
WALT DAVID RDirectorDec 23Sale184.565,000922,819864,830Dec 24 01:36 PM
WALT DAVID RDirectorDec 23Sale184.502,000369,00878,960Dec 24 01:36 PM
WALT DAVID RDirectorDec 16Sale178.355,000891,768869,630Dec 17 09:41 PM
Stapley MarcSr VP & CFODec 15Option Exercise36.301,42251,61925,706Dec 17 01:54 PM
Stapley MarcSr VP & CFODec 15Sale181.091,422257,50424,284Dec 17 01:54 PM
FLATLEY JAY TChief Executive OfficerDec 11Option Exercise20.0425,000501,000415,478Dec 12 07:00 PM
FLATLEY JAY TChief Executive OfficerDec 11Sale185.7925,0004,644,805390,478Dec 12 07:00 PM
WALT DAVID RDirectorDec 09Sale186.735,000933,645874,630Dec 11 08:02 PM
WALT DAVID RDirectorDec 09Sale186.792,000373,57680,960Dec 11 08:02 PM
BRADBURY DANIELDirectorDec 08Option Exercise42.821,60068,51214,066Dec 09 08:14 PM
BRADBURY DANIELDirectorDec 08Sale190.141,600304,21812,466Dec 09 08:14 PM
EASTHAM KARINDirectorDec 04Option Exercise42.8210,000428,20019,726Dec 05 07:54 PM
EASTHAM KARINDirectorDec 04Sale191.8710,0001,918,7259,726Dec 05 07:54 PM
Bouchard MichelChief Accounting OfficerDec 01Option Exercise69.3463143,75424,821Dec 02 05:36 PM
Ronaghi MostafaSr VP & CTODec 01Option Exercise44.3810,000443,80038,604Dec 02 05:35 PM
Bouchard MichelChief Accounting OfficerDec 01Sale187.43631118,26724,190Dec 02 05:36 PM
Ronaghi MostafaSr VP & CTODec 01Sale188.4610,0001,884,64528,604Dec 02 05:35 PM
FLATLEY JAY TChief Executive OfficerNov 28Option Exercise20.0425,000501,000406,262Dec 02 05:35 PM
Dadswell CharlesSr VP & General CounselNov 28Sale192.7615028,91442,089Dec 02 05:35 PM
FLATLEY JAY TChief Executive OfficerNov 28Sale189.7925,0004,744,761381,262Dec 02 05:35 PM
Bianchi Paul LSr VP, Human ResourcesNov 26Sale189.201,626307,63957,770Nov 26 07:19 PM
WHITFIELD ROY ADirectorNov 17Option Exercise19.614,00078,44015,738Nov 17 07:06 PM
WHITFIELD ROY ADirectorNov 17Sale178.264,000713,04011,738Nov 17 07:06 PM
Stapley MarcSr VP & CFONov 14Option Exercise36.301,42251,61923,533Nov 17 06:52 PM
Stapley MarcSr VP & CFONov 14Sale181.131,422257,56522,111Nov 17 06:52 PM
FLATLEY JAY TChief Executive OfficerNov 13Option Exercise20.0425,000501,000406,262Nov 14 06:06 PM
FLATLEY JAY TChief Executive OfficerNov 13Sale189.3225,0004,732,994381,262Nov 14 06:06 PM
Bouchard MichelChief Accounting OfficerNov 03Option Exercise69.3463143,75424,821Nov 05 06:10 PM
Ronaghi MostafaSr VP & CTONov 03Option Exercise44.3810,000443,80038,604Nov 05 06:09 PM
Bouchard MichelChief Accounting OfficerNov 03Sale195.68631123,47424,190Nov 05 06:10 PM
Ronaghi MostafaSr VP & CTONov 03Sale195.6610,0001,956,61328,604Nov 05 06:09 PM
BRADBURY DANIELDirectorOct 30Option Exercise42.822,10089,92214,566Oct 31 02:25 PM
BRADBURY DANIELDirectorOct 30Sale191.832,100402,83512,466Oct 31 02:25 PM
Dadswell CharlesSr VP & General CounselOct 27Sale189.8414727,90642,239Oct 28 12:17 PM
FLATLEY JAY TChief Executive OfficerOct 23Option Exercise20.0425,000501,000406,262Oct 24 12:07 PM
FLATLEY JAY TChief Executive OfficerOct 23Sale189.5425,0004,738,446381,262Oct 24 12:07 PM
Naclerio NicholasSr VP, Corp DevelopmentOct 15Option Exercise43.372,00086,74025,146Oct 16 08:09 PM
Naclerio NicholasSr VP, Corp DevelopmentOct 15Sale147.852,000295,70923,146Oct 16 08:09 PM
Stapley MarcCFOOct 14Option Exercise36.301,42251,61923,533Oct 16 07:49 PM
Stapley MarcCFOOct 14Sale151.481,422215,40322,111Oct 16 07:49 PM
BRADBURY DANIELDirectorOct 13Option Exercise42.822,10089,92214,566Oct 15 07:59 PM
BRADBURY DANIELDirectorOct 13Sale152.032,100319,25712,466Oct 15 07:59 PM
BOWMAN A BLAINEDirectorOct 07Option Exercise19.614,45687,38217,178Oct 07 07:28 PM
BOWMAN A BLAINEDirectorOct 07Sale159.514,456710,77512,722Oct 07 07:28 PM
BRADBURY DANIELDirectorOct 01Option Exercise42.822,10089,92214,566Oct 02 04:59 PM
Bouchard MichelChief Accounting OfficerOct 01Option Exercise69.3463243,82324,822Oct 02 04:59 PM
Ronaghi MostafaSr VP & CTOOct 01Option Exercise44.3810,000443,80038,604Oct 02 04:58 PM
BRADBURY DANIELDirectorOct 01Sale158.882,100333,64012,466Oct 02 04:59 PM
Bouchard MichelChief Accounting OfficerOct 01Sale158.57632100,21824,190Oct 02 04:59 PM
Ronaghi MostafaSr VP & CTOOct 01Sale159.8110,0001,598,08128,604Oct 02 04:58 PM
BOWMAN A BLAINEDirectorSep 30Option Exercise19.615,00098,05017,722Sep 30 07:59 PM
BOWMAN A BLAINEDirectorSep 30Sale164.025,000820,12312,722Sep 30 07:59 PM
RASTETTER WILLIAM HDirectorSep 29Sale163.7324840,6055,626Sep 30 07:59 PM
Dadswell CharlesSr VP & General CounselSep 29Sale163.7314724,06842,386Sep 30 07:59 PM
FLATLEY JAY TChief Executive OfficerSep 25Option Exercise20.0425,000501,000406,262Sep 26 05:54 PM
FLATLEY JAY TChief Executive OfficerSep 25Sale164.4325,0004,110,804381,262Sep 26 05:54 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 24Option Exercise53.1920,0001,063,80038,630Sep 24 07:38 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 24Sale167.2820,0003,345,62228,630Sep 24 07:38 PM
BOWMAN A BLAINEDirectorSep 23Option Exercise19.615,00098,05017,722Sep 24 07:38 PM
BOWMAN A BLAINEDirectorSep 23Sale168.505,000842,51012,722Sep 24 07:38 PM
BOWMAN A BLAINEDirectorSep 16Option Exercise19.615,00098,05017,722Sep 16 06:28 PM
BOWMAN A BLAINEDirectorSep 16Sale169.605,000847,98012,722Sep 16 06:28 PM
Stapley MarcSr VP & CFOSep 15Option Exercise36.301,42251,61923,533Sep 16 06:28 PM
Naclerio NicholasSr VP, Corp DevelopmentSep 15Option Exercise43.372,00086,74025,146Sep 16 06:28 PM
BRADBURY DANIELDirectorSep 15Option Exercise42.822,10089,92214,566Sep 16 06:28 PM
FLATLEY JAY TChief Executive OfficerSep 15Sale176.495,300935,413381,262Sep 15 08:14 PM
Stapley MarcSr VP & CFOSep 15Sale169.051,422240,38522,111Sep 16 06:28 PM
Naclerio NicholasSr VP, Corp DevelopmentSep 15Sale169.532,000339,05023,146Sep 16 06:28 PM
BRADBURY DANIELDirectorSep 15Sale168.572,100353,99112,466Sep 16 06:28 PM
FLATLEY JAY TChief Executive OfficerSep 11Option Exercise20.0425,000501,000406,262Sep 15 08:14 PM
FLATLEY JAY TChief Executive OfficerSep 11Sale175.9519,7003,466,126386,562Sep 15 08:14 PM
BOWMAN A BLAINEDirectorSep 09Option Exercise19.615,00098,05017,722Sep 10 09:09 PM
BOWMAN A BLAINEDirectorSep 09Sale178.085,000890,37712,722Sep 10 09:09 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 03Option Exercise53.1910,000531,90033,630Sep 04 06:36 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficSep 03Sale180.5910,0001,805,86128,630Sep 04 06:36 PM
Ronaghi MostafaSr VP & CTOSep 02Option Exercise44.3810,000443,80038,604Sep 03 08:11 PM